Prof. Dr. Stefan Olsson had a BSc in Biology 1980: Including advanced chemistry and specialization in Microbiology, Lund University, Sweden. 1980-1988 PhD studies in Microbiology at the section for Microbial Ecology. Also, a half-time Teaching assistant in Microbiology and Microbial Ecology. Thesis 1988 about competition between bacteria and a plant-parasitic fungus in the rhizosphere. 1988-1989 Postdoc in Liverpool, UK. Investigating nutrient translocation in fungal hyphae, Was there as a research fellow with my own grant from Sweden. 1989-1996 Postdoc doing own independent research mainly concerning fungal nutrient translocation, Lund Sweden 1996 Associate Professor at University of Copenhagen, Copenhagen, Denmark. That became part of the University of Copenhagen. Teaching Genome and Cell Biology MSc level. Research: Molecular biology of secondary metabolism in fungi, Bacterial-fungal interactions, Fungal innate immunity. 2016 Distinguished professor Fujian Agriculture and Forestry University, Fuzhou, China. Research: Fungal innate immunity, Molecular biology of plant-pathogen Interactions. 2018 Fujian Province Foreign Expert Reward.
Prof. Dr. BiljanaBozic Nedeljkovic is a Full professor of immunology at, Institute of physiology andbiochemistry, Faculty of Biology, University of Belgrade. From 2011 – 2017 sheis an Associate professor of immunology, Institute of physiology andbiochemistry, Faculty of Biology, University of Belgrade. Assistant professorof immunology, Institute of physiology and biochemistry, Faculty of Biology, The University of Belgrade. Recently she hasdone a project on an International scientific project on a Bilateralproject between the Ministry for Education and Science of The Republicof Serbia and the Slovenian Ministry for Science “The role of endonucleases in the hormone-induced neuroprotection in the experimental model of multiple sclerosis”. Research interests in Inflammation, Inflammatory cells, Immunomodulation by Natural productsand Synthetic compounds, Peripheral Nerve Injury, Neuroimmunology, Chronic Heart Failure, Autoimmunity.
Prof. Dr. Takuya Tsunoda is Chief Professor, Division of Medical Oncology, Department of Medicine, Showa University School of Medicine Director, Showa University Hospital Oncology Center. He is a Professor, Department of Clinical Immuno-oncology, Showa University. Editor in board: Trends of Immuno therapy, Cancer Biotherapy and Radiopharmaceuticals Frontiers in Oncology .Special instructor at Second department of Surgery, Wakayama School of Medicine. Special instructor at Fukushima School of Medicine. Executive Board member: Japanese Association of Biotherapy. Board member: Japanese Cancer Association, Japanese Association of Cancer Immunotherapy. Special Certificate: Special Doctor for Surgery and Gastrointestinal Surgery
Prof. Dr. Giulio Tarro, virologist; b. Messina, Italy, July 9, 1938; s. Emanuele and Emanuela (Iannello) Tarro; 1 adoptedchild, Giuseppe. MD, U. Naples, 1962, postgrad. in nervousdiseases, 1968, PhD in Virology, 1971; postgrad. in med. and bioI. scis., Roman Acad., 1979; degree in medicine (hon.), U. Pro Deo, Albany, NY, 1989; degree in immunology (hon.), St TheodoraAcad., NY, 1991; degree in bioethics (hon.), Constantinian U., Cranston, RI, 1996; MSc in Biomed. Techs. (hon.), ASAM U., Rome, 2008; degree in Social Scis. (hon.), Bonake U., Abidjan, Cote d'Ivoire, 2010. Asst. in med. pathologyNaples U., Italy, 1964-66; rsch. assoc. divsn. virology and cancerrsch. Children'sHosp., Cin., 1965-68; asst. prof. rsch. pediat, U. Cin. Coil. Medicine, 1968-69; rsch. fellow Nat. Rsch. COUll., Naples, 1966-74, rsch. chief, 1974; prof. oncologicvirology Call. Medicine U. Naples, 1971-85, prof. microbiology and immunologySch. Specialization, 1972-2006; chiefdivsn. virology D. Cotugno Hasp. InfectiousDiseases, Naples, 1973-2006, pres. ethic com., 1998-2007, head dept. diagnostic labs., 2003-06, emeritus, 2006-. Sr. scientist Nat. Cancer Inst. Frederick Ctr., Md., 1973; project dir. Nat Cancer Inst., Bethesda, Md., 1971-75; edn. min. rep. Zool. Sta., Naples, 1975-79; cons. ItalianPharmacotherapicInst., Rome, 1980-98, med. dir., 2006-07; nat. com. on bioethics, 1995-98; ethics com. Basilicata OncologicHosp., 2005-13; pres. De Beaumont Bonelli Found. Cancer Rsch., Naples, 1978-, European Group Econ. Interest, Rsch, and Devel., Naples, 2003-07, Campania Tech. and EcologyCtr., 2004-12; deanfacultynatural and phys. sets. Nobile Accademia di Santa Teodora Imperatrice, 1993-2003; dept. head medicine Naples People U., 2000-05; sci. coord. extracorporealhyperthermia in HCV patients First CircleMed., Mpls., 2000-03; vice chmn., gen. sec. sci. adv. bd. Unihart Biotech Pharm., London, 2005-07; chmn. com. on biotechs. and virusphere World Acad. Biomed. Techs., UNESCO, Paris, 2007-; adj. prof. deptbiology Temple U. Call. Sci. and Tech., Phila., 2007-, pres. sci. com. Moravia U. Gonzaga Inst. Naples, 2008-09, pres. Norman Acad. Rome, 2009-. Natcom. On health, 2013. Author: Virologia Oncologica, 1979, Patologia dell'AIDS, 1991, Can iI Cancro si PUG Vivere, 1992, AIDS Cosa Possiamo Fare Cosa Dobbiamo Sapere, 1994, Pocket File Research Collection, 1997, 6th edit., 2003, To PreventIs To Win, 1998, Bioethics and Culture of Prevention, 2001, HealthWithoutBorders, 2004, 5th edit., 2012, Safety No Limits, 2008, Campania Land of Poisons, 2012, Medicine is Life; 2013; editor-in- chief: Internal. Jour. Clin. Investigation, 2000-10, Cotugno News, 2003-09, Fratres, 2004-; Journal of Vaccine and Development, 2015 -; contbr. more than 490 articles to profl. jours.Pres. Sci. Cultural Com., Torre Annunziata, Italy, 1984, TumorPreventionAssn., Rome, 1984; memacadsenateConstantinian U., Providence, 1990, U. Pro Deo, NY, 1994; hon. acad U. SanctiCyrilli, Valletta, Malta, 2001; mem UNESCO-Hebrew U. Jerusalem Internat. Sch. MolecularBiology and Microbiology, hon. rector Ruggero II U., Fla., 2003, pres., 2013-. Maj. Italian Navy, 1982-84, Lt. col., 1993-95, mem UN Internat. Computing Sci. Acad., 1997, mem Lions Found., 1990-91 Decoratedcomdr, Nat. Order of Merit, Star of Europe, knightgrand cross SovereignConstantinian Order St, George, gtofficerItalian Republic; recipientInternal.
Prof. Dr. Raul Ramos is a Medical Doctor and Immunology Specialist from Havana Medical University, Cuba. His Ph.D. thesis is on the mechanism of a vaccination strategy in cooperation with the Hasselt University, Belgium. He is the Head of the Immunology Department and Associate Professor of Havana Medical University. He is the Chairof the Teaching Section of Cuban Society for Immunology and the General Secretary of Latin America and Caribbean Association of Immunology (ALACI). He has several presentations in international conferences and articles published in international journals. He supervises several Master’s students and Medical Doctors specializing in Immunology. He is researching in the fields of Mucosal Immunology and Vaccinology, currently focused on COVID-19.
Prof. Dr. Emilio Malchiodi (Scopus author ID: 7003348179; ORCID #: 0000-0001-7501-3330) is Biochemist and Dr. in Immunology from the University of Buenos Aires, Argentina. His Ph.D. Thesis was on Chagas disease differential diagnosis. He completed postdoctoral studies at the University of Maryland working in Biophysics and determination of three-dimensional structure of proteins of immunological interest by X-ray crystallography. He is currently Professor and Chair of Immunology at Universidad de Buenos Aires, and Director of the Instituto de Estudios de la Inmunidad Humoral Prof. Ricardo Margni (UBA-CONICET).He has been Secretary of Argentinian Association for Microbiology and President of Argentinian Society of Protozoology and its Congress; he will be Future President (2021-2022) of Immunology Society of Argentina and Future President (2021-2024) of the Latin America and Caribbean Association of Immunology (ALACI). He is currently member of the IUIS Vaccine Committee. He has received numerous national and international grants to conduct research in the field of vaccines against parasitic diseases and in the interaction of macromolecules of the immune system that have led to the publication of more than 115 papers in scientific journals (Google Scholar: 4630 citations; h-index: 39). He isAssociate Editor of Frontiers in Microbial Immunology. He is currently developing the following vaccines 1- Chagas Disease based on chimeric antigens and last generation adjuvants; 2- Yellow fever based on Virus Like Particles (VLP) and baculovirus; and 3- Leishmaniasis based on reverse vaccinology.
Prof. Dr. Bogdan Petrunov is one of the leading specialists in the field of immunology and allergology in Bulgaria. He graduated in 1960 cum laude form Medical University in Sofia where he obtained his MD, PhD and DSc degrees. He has specialized in Czech Republic, England, France, USA, Netherlands. He founded in 1963 in the National Center of Infectious and Parasitic Diseases the first Laboratory of Allergy in the country which he rules until now. He is lecturing allergology and immunology in Medical University, Sofia. As a guest –professor he has delivered lectures in USA, Canada, Russia, Libya, Czech Republic, India, Cuba, Australia. He is a member of the European Academy of Allergy and Clinical Immunology, Foreign Member of Russian Academy of Sciences, Honorary Member of World Immunopathology Organization, President of the Bulgarian Society of Allergy. In 2004 he has been elected as an Academician of Bulgarian Academy of Sciences. In 2007 he was appointed as representative of Bulgaria in the European Medical Research Council to the European Commission. His main interests are in the field of mechanism of action of atopic allergens , in vitro diagnosis and allergen specific immunotherapy of allergic diseases, immunomodulation, air pollution and hyprsensitivity. He has published more than 220 articles in different international journals. He is graduated with many national and international honorable awards for merit in recognition for his professional and scientific contribution.
My research is in the field of infectious disease and has focused on viral immunology and immunopathology. We have mainly studied herpes simplex virus (HSV) infection in mice both with a view to devising successful vaccines and more particularly to determine how HSV causes tissue damage in critical tissues such as the eye and nervous system. We have worked on both host innate and adaptive immune mechanisms, particularly the T cells responsible for immunity as well as those involved in orchestrating tissue damage. We have defined the role of several subtypes of proinflammatory T cells as well as numerous cytokines and chemokines. Our group was the first to show a role of regulatory T cells (Treg) in the host response to a virus infection. We demonstrated that Treg responses could act to inhibit the efficiency of immunity, but that Treg were valuable to modulate the severity of immunopathological responses, such as those that occur in the corneal stroma after HSV infection of the eye. My group has studied the important blinding lesion herpes stromal keratitis (SK) for >30 years and has demonstrated how multiple events set off by ocular HSV infection culminate in SK. We have paid particular attention to the non-specific inflammatory cells, particularly neutrophils, that are recruited to the eye and which appear to be mainly responsible for the tissue damage that occurs. We were also the first to show a critical role for corneal neovascularization (CV) during SK pathogenesis, identified several angiogenic factors and studied how such factors are generated following HSV infection. We have also investigated how to diminish the extent of CV and showed that controlling CV represents a valuable means of therapy, particularly if combined withapproaches that control other critical events in lesion pathogenesis. Recently, we have also investigated variousways ofmodulating the extent of proinflammatory T cell involvement during SK with a view to understanding how to optimally achieve lesion resolution. The basic objective is now to find convenient ways to change the balance of T cell subsets involved in inflammatory reactions to favor those with an anti-inflammatory function. To this end, we became involved in manipulating metabolic pathways since different cell subtypes use different pathways. We discovered that suppressing glucose utilization with 2 deoxyglucose (2DG) was a convenient approach to control SK lesion severity. However, we also made the unexpected discovery that using 2DG during the acute phase of infection enhanced virus replication and diminished immune responses that normally function to stop virus from spreading to the CNS. This finding was the inspiration for the present proposal since we believe we may have found a possible explanation for the occurrence of the rare lesion of herpes encephalitis caused by HSV-1 in adults.
Dr. Subbaya Subramanian is a cancer researcher who completed his postdoctoral fellowship at Stanford University. Dr. Subramanian is currently working as an Associate Professor in the Department of Surgery at the University of Minnesota. As a faculty at the University of Minnesota, he has established an internationally recognized cancer research program focused on deciphering the molecular mechanisms of colorectal cancer development and progression. His current research focuses on understanding the interactions between cancer and the host immune system and how cancer cells manipulate the anti-tumor immune response. His goal is to translate the knowledge gained into valid therapeutic targets and to develop novel clinical applications. Dr. Subramanian is an author of over 100 peer-reviewed publications and has written numerous book chapters and review articles. He is the Associate Editor-in-Chief of the journal Cancers and serves as the Section Editor-in-Chief of Vaccines. Dr. Subramanian also serves on the Editorial Board of several journals including Scientific Reports. He is a co-founder and Chief Scientific Officer of EV Therapeutics Inc., which develops exosome-based cancer therapies for advanced-stage cancers.
Patrícia Alexandra Curado Quintas Dinis Poeta, Full Professor at the University of Trás-os-Montes and Alto Douro (UTAD), EBVS® European Specialist in Veterinary Microbiology and ESGVM Executive Committee of ESCMID. Member of LAVQ-REQUIMTE, Chemistry Department, Faculty of Science and Technology, University NOVA of Lisbon. PhD in Veterinary Medicine by UTAD and Coordinator of the Research Group MicroArt- Microbiology and Antibiotic resistance Team and Head of Medical Microbiology Laboratory. Her main research interest is the characterization of antibiotic resistance mechanisms in bacteria of different origins as humans, animals, food, water and the environment, as well as the performance of studies of molecular epidemiology to characterize the genetic lineages of antibiotic resistant bacteria. Director of several doctoral and masters’ theses. Also responsible for research projects funded by private companies and inter-university projects, teaches International courses and Master’s degree and keeps working activities with several national and international entities. With regard to scientific production has published more than 200 articles in journals from the SCI and book chapters. Has more than 500 communications at international scientific meetings, presentations at national or Iberian scientific meetings, posters at scientific meetings, publications in GenBank, publications in UniProt, records in MLST, technical and scientific journals and series or educational work. Received 37 awards. Operates in the areas of Veterinary Science. In professional activities interacted with 175 workers in authorship and co-authorship of scientific papers.
Director, 2016 to Present. Independent pathology consultant specializing in histopathological and immunohistochemical evaluation of sponsored adequate and well- controlled efficacy studies focused on prophylactic and post-exposure product development for CDC and USDA Special Pathogens Agents in BSL-3 and BSL-4 environments.M.S., Strategic Studies, U.S. Army War College, Carlisle, PA, 2001. USDA Accredited Foreign Animal Disease Diagnostician, 1998. Diplomate, American College of Veterinary Pathologists, 1992. Residency, Comparative Pathology, Walter Reed Army Institute of Research, Armed Forces Institute of Pathology, Washington D.C.1992. DVM, Washington State University, Pullman, WA, 1983.
Prof. Dr. Sergey Suchkov was born in the City of Astrakhan, Russia, in a family of dynasty medical doctors. In 1980, graduated from Astrakhan State Medical University and was awarded with MD. In 1985, maintained his PhD as a PhD student of the I.M. Sechenov Moscow Medical Academy and Institute of Medical Enzymology, USSR Academy of Medical Sciences. In 2001, maintained his Doctor Degree at the National Institute of Immunology, Russia. From 1985 through 1987, worked as a Post Doc Research Associate, for Institute of Medical Enzymology; from 1987 through 1989, was a Senior Research Associate, Koltzov Institute of Developmental Biology, USSR Academy of Sciences. From 1989 through 1995, was a Head of the Lab of Immunology and Immunobiotechnology, Helmholtz Eye Research Institute in Moscow. In 1989, trained at the Lab of Immunology, NEI, Bethesda, MD, USA,, NIH and Lab of Immunology, Wills Eye Hospital, Philadelphia, USA, as well as at some of the British Universities on the invitation of the Royal Society for Immunology. From 1995 through 2004, was a Director of the Dept for Immu-nology, Moscow Clinical Research Institute (MONIKI). In 1993-1996, was an Executice Secretary-in-Chief of the Editorial Board, Biomedical Science, an international journal published jointly by the USSR Academy of Sciences and the Royal Society of Chemistry, UK.
Will upload soon..
Prof. Dr. Jawhar Gharbi obtained his MSc (1995) in Molecular Genetic and his PhD (1999) degrees in Molecular Virology from the University of Tunis ElManar, Tunisia. He obtained the international diploma of Fundamental Virology from the Pasteur Institute of Paris, France in 1997. He also gained the Habilitation (HDR) in Virology from the University of Monastir, Tunisia in 2006. Afterwards, he received a one-year postdoctoral research as Fulbright scholarship at the University of Nebraska Medical Center UNMC, Omaha, USA. He was named Assistant Professor in 1999 at the University of Carthage than in the University of Sousse, Tunisia.In 2006, he was named Associate Professor and as a full Professor ofVirology in 2011 at the University of Monastir, Tunisia. From 2011 to 2017, Professor Jawhar GHARBI has been appointed deputy director of the Higher Institute of Biotechnology of Monastir. His research focuses on viral epidemiology, viral pathogenesis and virulence, vaccines development for RNA+ viruses. He has co-published about 50 papers in indexed journals. He has been involved as Principal Investigator in establishing several joint scientific projects with Moroccan, French, German, spain and indian scientists aiming at studying the circulation, pathogenesis and control of viruses. He is co-founder of the Tunisian Society of Microbiology in 2007 and founder of the Tunisian Association of Genomics in 2010.He was invited as visiting professor in several worldwide universities and research centers. Professor GHARBI Jawhar is actually the head of the Research Unit UR17ES30 “Virology and Antiviral Strategies” and the USCR-SAG Unit “Genomic sequencing and analysis” at the University of Monastir.
Prof. Dr. Milind Madhukar Gore,for PhD I worked on CMI of GBS ATM. Worked at Wistar Institute on Rabies. Further Ideveloped diagnostics, peptide, DNA vaccine against JE along with innate and protective immune response. Iestablished NIV Gorakhpur Unit, in Eastern Uttar Pradesh to work on encephalitis patients, vaccine efficacy of attenuated JE vaccine. I developed anti enterovirus IgM ELISA test. I contributed in public health in different regions of India. I am combining all this in terms of vaccine development to keep in mind clinical side effects, morbidity and autoimmunity. I want to work on West Nile, influenza vaccine and differential diagnostics of JE WN DEN. Guide of seven PhD students with 70 publications.